Literature DB >> 11678172

Long-term objective and subjective audiologic consequences of closed head injury.

P O Bergemalm1, E Borg.   

Abstract

During a period of 5 years, a total of 47 patients, 16-60 years of age, with major closed head injury (CHI) were admitted to 2 Swedish medical centres. Seven to 11 years after injury, 25 of them (mean age 40.8 years; range 25-59 years) were evaluated using peripheral and central auditory tests, and most of them also completed 2 questionnaires concerning self-assessed hearing ability and quality of life. Twenty-two patients did not participate in the long-term follow-up tests: 15 were excluded for medical reasons and 4 did not wish to participate; an additional 2 were impossible to trace and 1 had died. As many as 68% of patients (17/25) demonstrated abnormalities on 1 or more of the audiometric tests, 14 on pure-tone audiometry (p < 0.02) and/or central audiometric tests (3 on central tests only and 2 on pure-tone audiometry only). Four out of six patients with available early post-traumatic audiograms showed a significant progressive deterioration. As a group, their assessments of hearing ability and quality of life were equal to or better than those of the controls. These results may indicate that a higher priority should be given to obtaining an early audiologic evaluation of every CHI patient than is the rule today. The impact of post-traumatic progress and central lesions on social hearing at an advanced age is highlighted.

Entities:  

Mesh:

Year:  2001        PMID: 11678172     DOI: 10.1080/00016480152583674

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  10 in total

1.  Quality of life and impairment in patients with multiple sclerosis.

Authors:  A-K Isaksson; G Ahlström; L-G Gunnarsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

2.  Brainstem Evoked Potential Indices of Subcortical Auditory Processing After Mild Traumatic Brain Injury.

Authors:  Kathy R Vander Werff; Brian Rieger
Journal:  Ear Hear       Date:  2017 Jul/Aug       Impact factor: 3.570

Review 3.  The Application of the International Classification of Functioning, Disability and Health to Functional Auditory Consequences of Mild Traumatic Brain Injury.

Authors:  R Vander Werff Kathy
Journal:  Semin Hear       Date:  2016-08

4.  Auditory and Cognitive Factors Associated with Speech-in-Noise Complaints following Mild Traumatic Brain Injury.

Authors:  Eric C Hoover; Pamela E Souza; Frederick J Gallun
Journal:  J Am Acad Audiol       Date:  2017-04       Impact factor: 1.664

5.  Auditory and Cognitive Behavioral Performance Deficits and Symptom Reporting in Postconcussion Syndrome Following Mild Traumatic Brain Injury.

Authors:  Kathy R Vander Werff; Brian Rieger
Journal:  J Speech Lang Hear Res       Date:  2019-07-01       Impact factor: 2.297

6.  Risk of Ear-Associated Diseases After Zygomaticomaxillary Complex Fracture.

Authors:  Chao-Chih Yang; Chih-Jaan Tai; Sou-Hsin Chien; Cheng-Li Lin; Shih-Ni Chang; Fung-Chang Sung; Chi-Jung Chung; Chia-Hung Kao
Journal:  J Maxillofac Oral Surg       Date:  2015-02-13

7.  Anosmia associated with hearing loss and benign positional vertigo after head trauma.

Authors:  G Ottaviano; G Marioni; R Marchese-Ragona; C P Trevisan; C De Filippis; A Staffieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-10       Impact factor: 2.124

8.  Sudden post-traumatic sensorineural hearing loss reverted to normal by sneezing.

Authors:  Alper Yenigun
Journal:  SAGE Open Med Case Rep       Date:  2014-12-17

Review 9.  Prosodic processing post traumatic brain injury - a systematic review.

Authors:  Gabriela Ilie; Michael D Cusimano; Wenshan Li
Journal:  Syst Rev       Date:  2017-01-04

10.  Effects of Signal Type and Noise Background on Auditory Evoked Potential N1, P2, and P3 Measurements in Blast-Exposed Veterans.

Authors:  Melissa A Papesh; Alyssa A Stefl; Frederick J Gallun; Curtis J Billings
Journal:  Ear Hear       Date:  2021 Jan/Feb       Impact factor: 3.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.